tiprankstipranks
Trending News
More News >
ADJUVANT HOLDINGS CO., LTD. (JP:4929)
:4929
Japanese Market
Advertisement

ADJUVANT HOLDINGS CO., LTD. (4929) AI Stock Analysis

Compare
0 Followers

Top Page

JP:4929

ADJUVANT HOLDINGS CO., LTD.

(4929)

Rating:55Neutral
Price Target:
¥779.00
▼(-1.02%Downside)
The overall score is primarily influenced by a strong financial position, despite concerns over revenue trends and cash flow growth. Technical analysis indicates bearish momentum, while the high P/E ratio suggests overvaluation. The absence of earnings call data and corporate events limits additional insights.

ADJUVANT HOLDINGS CO., LTD. (4929) vs. iShares MSCI Japan ETF (EWJ)

ADJUVANT HOLDINGS CO., LTD. Business Overview & Revenue Model

Company DescriptionADJUVANT HOLDINGS CO., LTD. (4929) is a company engaged in the development, manufacturing, and sale of cosmetics and skincare products. The company operates in the beauty and personal care sector, providing a range of high-quality products designed to enhance beauty and skin health. Its core offerings include facial care, body care, and hair care products, catering to a diverse consumer base seeking effective and innovative skincare solutions.
How the Company Makes MoneyADJUVANT HOLDINGS CO., LTD. generates revenue primarily through the sale of its cosmetics and skincare products. The company employs a multi-channel sales strategy, distributing its products through direct sales, retail outlets, and online platforms. It also leverages partnerships with beauty salons and spas to expand its market reach and brand presence. The company's revenue streams are bolstered by its commitment to research and development, ensuring a steady pipeline of new and improved products that meet consumer demands for quality and effectiveness.

ADJUVANT HOLDINGS CO., LTD. Financial Statement Overview

Summary
ADJUVANT HOLDINGS CO., LTD. demonstrates a sound financial position with strong gross margins and a solid balance sheet, supported by prudent leverage. However, challenges such as inconsistent revenue growth and net profit margins, along with fluctuating cash flow metrics, indicate areas needing attention. Overall, the financial health is stable but requires focus on improving growth consistency and profitability.
Income Statement
65
Positive
The company shows a volatile revenue pattern with a recent decline in revenue growth. The gross profit margin remains healthy, but net profit margins show instability due to fluctuating net income. While EBIT and EBITDA margins have improved recently, historical inconsistency affects overall performance.
Balance Sheet
75
Positive
The balance sheet is strong with a low debt-to-equity ratio, indicating prudent leverage. The equity ratio reflects a solid asset base supported by equity. Return on equity is inconsistent due to fluctuating net income, but the overall position remains stable.
Cash Flow
70
Positive
Cash flow metrics show a moderate performance with fluctuations in free cash flow growth. The operating cash flow to net income ratio is robust, indicating efficient cash generation relative to earnings. However, variability in free cash flow to net income indicates some uncertainty in cash management.
BreakdownMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue4.10B4.44B4.38B4.43B4.89B
Gross Profit2.66B2.86B2.92B2.94B3.00B
EBITDA259.63M124.00M697.06M500.79M292.22M
Net Income40.73M-99.86M403.64M393.18M142.38M
Balance Sheet
Total Assets5.29B5.28B5.55B5.66B5.10B
Cash, Cash Equivalents and Short-Term Investments2.22B2.12B1.53B1.74B1.47B
Total Debt30.51M30.82M19.18M30.08M22.96M
Total Liabilities1.11B1.06B1.06B1.34B1.00B
Stockholders Equity4.18B4.22B4.49B4.32B4.09B
Cash Flow
Free Cash Flow301.91M314.89M-422.66M369.44M317.90M
Operating Cash Flow307.99M377.61M-321.67M417.88M403.11M
Investing Cash Flow-95.61M391.20M344.97M24.39M-235.19M
Financing Cash Flow-104.55M-198.21M-256.90M-179.73M-169.56M

ADJUVANT HOLDINGS CO., LTD. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price787.00
Price Trends
50DMA
765.96
Negative
100DMA
778.35
Negative
200DMA
793.61
Negative
Market Momentum
MACD
-0.97
Positive
RSI
45.10
Neutral
STOCH
6.22
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4929, the sentiment is Negative. The current price of 787 is above the 20-day moving average (MA) of 783.00, above the 50-day MA of 765.96, and below the 200-day MA of 793.61, indicating a bearish trend. The MACD of -0.97 indicates Positive momentum. The RSI at 45.10 is Neutral, neither overbought nor oversold. The STOCH value of 6.22 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4929.

ADJUVANT HOLDINGS CO., LTD. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
¥42.99B31.23
1.37%2.52%-7.44%
69
Neutral
¥11.79B57.48
3.07%4.75%-83.63%
65
Neutral
$27.23B15.60-4.43%2.56%1.05%4.97%
61
Neutral
¥6.23B10.81
2.43%-2.13%
57
Neutral
¥8.01B10.99
-17.95%
55
Neutral
¥6.11B158.30
1.58%-9.81%
45
Neutral
¥4.93B36.16
1.74%0.10%-239.09%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4929
ADJUVANT HOLDINGS CO., LTD.
760.00
-97.44
-11.36%
JP:4923
Cota Co., Ltd.
1,447.00
-167.10
-10.35%
JP:4925
HABA Laboratories, Inc.
1,648.00
-318.66
-16.20%
JP:4926
C'BON COSMETICS Co., Ltd.
1,151.00
-225.64
-16.39%
JP:4934
Premier Anti-Aging Co., Ltd.
919.00
25.00
2.80%
JP:4936
AXXZIA, Inc.
489.00
-414.75
-45.89%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 28, 2025